We found that increased CCNG2 expression could inhibit proliferation, induce G0/G1 phase arrest, and promote apoptosis in glioma cells in vitro and that levels of CCNG2 are mediated by AKT. The gene discussed is AKT1; the disease is central nervous system cancer.